本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kiniksa Pharmaceuticals Ltd.

33.70
+0.13000.39%
盘后34.320.6194+1.84%16:23 EDT
成交量:34.95万
成交额:1,179.30万
市值:24.97亿
市盈率:510.33
高:34.16
开:33.57
低:33.36
收:33.57
52周最高:34.55
52周最低:17.82
股本:7,410.77万
流通股本:3,355.22万
量比:0.89
换手率:1.04%
股息:- -
股息率:- -
每股收益(TTM):0.0660
每股收益(LYR):-0.6047
净资产收益率:1.03%
总资产收益率:0.46%
市净率:5.05
市盈率(LYR):-55.73

数据加载中...

2025/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/03

重要事件披露

Form 8-K - Current report
2025/05/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/29

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/29

重要事件披露

Form 8-K - Current report
2025/04/23

重要事件披露

Form 8-K - Current report
2025/04/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities